Catching up but still miles behind-a patient registry for otoferlin.
Barbara Vona, Bernd Wollnik, Nicola Strenzke...
https://pubmed.ncbi.nlm.nih.gov/38825639/Actively Recruiting
Led by Tobias Moser · Updated on 2025-05-28
100
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to gather detailed information about individuals with hereditary hearing impairment linked to variants in the otoferlin OTOF gene. The study focuses on understanding the natural history of otoferlin-associated hearing loss, identifying types of genetic variants involved, and supporting clinical and basic research in this area. The registry is bilingual, available in German and English, and operates under ethical approval in line with the Declaration of Helsinki. Participants with otoferlin-associated hearing loss are enrolled in a patient registry where genetic testing and audiometry are the main diagnostic assessments. The study does not involve experimental treatments but collects clinical and genetic data from individuals with confirmed molecular genetic diagnoses involving otoferlin. This observational study is designed to improve long-term knowledge and help tailor future therapies and care for affected individuals. Participants will be evaluated using several hearing tests, including pure-tone audiometry and speech audiometry, typically within one year following consent. Additional assessments may include otoacoustic emission thresholds and auditory brainstem response tests. The study captures comprehensive clinical and genetic information to better characterize hearing impairment related to otoferlin and monitor outcomes over time, with the possibility of follow-up as consented by participants.
CONDITIONS
Otoferlin Patient Registry and Natural History Study
B
Barbara Vona, PhD
T
Tobias Moser, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Tobias Moser
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year according to participant consent
Participants undergo molecular genetic testing and audiometry to assess hearing impairment associated with otoferlin variants.
Visits as needed for audiometry and genetic testing
Duration - Up to 1 year according to participant consent
Participants are monitored to understand the natural history of otoferlin-associated hearing loss through periodic audiometric assessments.
Visits according to participant consent over 1 year
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Barbara Vona, Bernd Wollnik, Nicola Strenzke...
https://pubmed.ncbi.nlm.nih.gov/38825639/Tobias Moser
Lead Sponsor